Vitamin D and Cathelicidin (LL-37) Status in Patients with Type 2 Diabetes and Staphylococcus aureus Nasal Carriage
Open Access
- 1 August 2021
- journal article
- research article
- Published by Raiya Academic International LLC in The Review of Diabetic Studies
- Vol. 17 (1) , 30-37
Abstract
OBJECTIVE: Type 2 diabetes mellitus (T2D) is characterized by the dysregulation of innate immunity leading to higher rates of Staphylococcus aureus nasal carriage, an important risk factor for severe infections. 25-hydroxy vitamin D (25(OH) D) may contribute, via the production of the antimicrobial peptide cathelicidin (LL-37), to epithelial host defense against S. aureus . This study evaluated whether 25(OH)D and LL-37 levels determine S. aureus nasal carriage. METHODS: Two consecutive nasal swabs were obtained from 118 T2D patients to determine S. aureus nasal carriage status. Serum levels of 25(OH)D and LL-37 were measured using chemiluminescence immunoassay and enzyme-linked immunosorbent assay, respectively. Supplementation of vitamin D by a number of participants was taken into account and evaluated. RESULTS: Forty-two T2D patients (35.6%) were found to be colonized by S. aureus . Vitamin D deficiency was detected in sixty-nine patients (65.7%). Median value for LL-37 in T2D patients was 0.89 ng/ml (range 0.05-8.62 ng/ml). Circulating levels of LL-37 were higher in nasal carriers compared to non-carriers (1.25 ng/ml vs 0.72 ng/ml; p < 0.001). No difference was found in serum 25(OH) D levels between carriers and non-carriers. 25(OH)D and LL37 serum levels correlated positively in non-carriers, while the relationship was inversed in the carrier group. Vitamin D supplementation was not associated with lower incidence of S. aureus nasal carriage (p = 0.706). CONCLUSIONS: T2D patients presented decreased serum levels of 25(OH)D and LL-37, indicating a potential impairment of innate immunity. Expression of LL-37 may be induced by S. aureus nasal carriage among people with diabetes. Vitamin D supplementation did not influence S. aureus nasal colonization in T2D patients.Keywords
This publication has 37 references indexed in Scilit:
- Effect of vitamin D3 supplementation on Staphylococcus aureus nasal carriage: a randomized, double-blind, placebo-controlled trial in healthy adultsClinical Microbiology and Infection, 2014
- Measurement of vitamin D and cathelicidin (LL-37) levels in patients of psoriasis with co-morbiditiesIndian Journal of Dermatology, Venereology and Leprology, 2013
- Differential expression of antimicrobial peptides in active and latent tuberculosis and its relationship with diabetes mellitusHuman Immunology, 2011
- Circulating levels of 25-hydroxyvitamin D and human cathelicidin in healthy adultsJournal of Allergy and Clinical Immunology, 2011
- Vitamin D and methicillin-resistant Staphylococcus aureus nasal carriageScandinavian Journal of Infectious Diseases, 2010
- Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsisJournal of Translational Medicine, 2009
- Vitamin D-Directed Rheostatic Regulation of Monocyte Antibacterial ResponsesThe Journal of Immunology, 2009
- Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 2008
- What determines nasal carriage of Staphylococcus aureus?Trends in Microbiology, 2001
- Determinants of Staphylococcus aureus Nasal CarriageClinical and Diagnostic Laboratory Immunology, 2001